ABALLI JOHN (President and CEO) sold 4.1% of their position (34.29K shares) of EXAGEN INC. on the open market
Open‑market sale worth $269.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/19/2026ACC: 0001843113-26-000009
DirectorOfficer· President and CEO
Since Mar 2026
-34.29K
Net shares
Net seller
$269.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
34.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−34.29K
Price / share
$7.87
Trade value
$269.79K
% of position
4.1%
10/16/2026
839.83K→805.54K
Total
Net shares
−34.29K
Net value
-$269.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/16/2026 | S · Sale | −34.29K | $7.87 | $269.79K | 4.1% | 839.83K | 805.54K |
| Total | −34.29K | -$269.79K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned40.40K
Total
40.40K indirect40.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.40K | Indirect |
| Total | 40.40K | 40.40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported